By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous topical agents > Eflornithine topical > Eflornithine Topical Dosage
Miscellaneous topical agents
https://themeditary.com/dosage-information/eflornithine-topical-dosage-8400.html

Eflornithine Topical Dosage

Drug Detail:Eflornithine topical (Eflornithine topical [ ee-floor-nih-theen ])

Drug Class: Miscellaneous topical agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hirsutism

Apply a thin layer to the affected area(s) of the face and under the chin twice a day allowing at least 8 hours between applications

Comments:

  • This drug has only been studied on the face and adjacent involved areas under the chin and therefore usage should be limited to these areas of involvement.
  • The treated area should not be washed for at least 4 hours.
  • The patient should continue to use hair removal techniques in conjunction with this drug with application of this cream at least 5 minutes after hair removal.

Use: For the reduction of unwanted facial hair in women

Usual Pediatric Dose for Hirsutism

12 years or older: Apply a thin layer to the affected area(s) of the face and under the chin twice a day allowing at least 8 hours between applications

Comments:

  • This drug has only been studied on the face and adjacent involved areas under the chin and therefore usage should be limited to these areas of involvement.
  • The treated area should not be washed for at least 4 hours.
  • The patient should continue to use hair removal techniques in conjunction with this drug with application of this cream at least 5 minutes after hair removal.

Use: For the reduction of unwanted facial hair in women

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

If skin irritation or intolerance develops, temporarily reduce frequency of application (e.g., once a day); if irritation continues, consider discontinuing treatment.

Precautions

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For topical dermatological use only; not for ophthalmic, oral, or intravaginal use.
  • Rub in thoroughly
  • Apply at least 5 minutes after using hair removal products
  • Cosmetics or sunscreens may be applied over treated area once cream has dried.

Storage requirements:
  • Store at room temperature; do not freeze.

General:
  • Onset of improvement has been observed within 4 to 8 weeks of treatment; however, the condition may return to pretreatment levels 8 weeks after discontinuing treatment.

Patient advice:
  • Continue using a hair removal method in conjunction with this drug.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by